Ironwood

Ironwood is a pharmaceutical company that develops and markets medicines for the treatment of irritable bowel syndrome and chronic idiopathic constipation. Read more

Thomas McCourt's photo - Interim-CEO of Ironwood

Interim-CEO

Thomas McCourt

CEO Approval Rating

83/100

Founded:

1998

Status:

PublicIndependent CompanyNASDAQIRWD

IRONWOOD TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Albireo is perceived as one of Ironwood's biggest rivals. Albireo's headquarters is in Boston, Massachusetts, and was founded in 2008. Albireo operates in the Pharmaceuticals industry. Albireo generates 2.19% of Ironwood's revenue.

Ardelyx has been one of Ironwood's top competitors. Ardelyx is a Public company that was founded in 2007 in Fremont, California. Ardelyx operates in the Biotechnology industry. Compared to Ironwood, Ardelyx has 386 fewer employees.

Endo is Ironwood's #3 rival. Endo was founded in Ballsbridge, County Dublin} in 1997. Endo is in the Pharmaceuticals industry. Compared to Ironwood, Endo generates $2.4B more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Evoke Pharma Inc a competitor of Ironwood?

Ironwood Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$398.4M

Ironwood's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 354.9M. Over the last four quarters, Ironwood's revenue has decreased by 0.7%. Specifically, in Q1 2021's revenue was $88.8M; in Q4 2020, it was $116.7M; in Q3 2020, it was $103.5M; in Q2 2020, Ironwood's revenue was $89.4M.

Ironwood Acquisitions

No recent acquisitions found related to Ironwood

Ironwood Funding History

Since Ironwood was founded in 1998, it has participated in 8 rounds of funding. In total Ironwood has raised $652.8M. Ironwood's last funding round was on Sep 2016 for a total of $150.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Sep 2016
$150M
-
Debt
Jan 2013
$175M
-
IPO
Feb 2010
$187.5M

Equity
Nov 2009
$15M
-
Equity
Aug 2009
$25M
-

Since Ironwood was founded in 1998, it has participated in 8 rounds of funding. In total Ironwood has raised $652.8M. Ironwood's last funding round was on Sep 2016 for a total of $150.0M

Ironwood Investments

No recent investments found related to Ironwood

Ironwood News

February 19, 2021MarketScreener

to Present at Upcoming Investor Conferences

(marketscreener.com) Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, announced that... See more »
February 8, 2021Seeking Alpha

Ironwood Pharma's CEO Mark Mallon to step down

Ironwood Pharma (NASDAQ:IRWD) announced that Mark Mallon plans to step down as its chief executive of... See more »
February 3, 2021BioSpace

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Investor Update Call

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its fourth quarter and ful... See more »
January 5, 2021MarketScreener

to Present at the 39th Annual J.P. Morgan Healthcare Conference

(marketscreener.com) Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, will provide a... See more »
December 3, 2020Boston Citybizlist

Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the appointment of Jay P. Shepard to it... See more »

Ironwood Press Releases

May 1, 2018PR Newswire

Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action

DUBLIN and CAMBRIDGE, Mass., May 1, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global p... See more »
March 5, 2018EconoTimes

Positioning to Benefit within Ironwood Pharmaceuticals, Altaba, The AES, PACCAR, NVR, and WPX Energy - Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its lat... See more »
October 31, 2017Business Wire

Diabetic Gastroparesis - Global Clinical Trials Review, H2, 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Diabetic Gastroparesis Global Clinical Trials Review, H2, 2017" clinica... See more »
April 12, 2017Blackbird

Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)

DUBLIN and CAMBRIDGE, Mass., April 13, 2017 /PRNewswire/ - Allergan plc (NYSE: AGN) and Ironwood Phar... See more »
January 4, 2017Blackbird

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.-(BUSINESS WIRE)-Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corpora... See more »
November 1, 2016Business Wire

Ironwood Pharmaceuticals to Present at Credit Suisse 25th Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corpo... See more »

Ironwood Videos

March 6, 2017Ironwood Pharmaceuticals Youtube Channel

"Our Core Values: Ironwoodian, Marian R., on Ownership" on YOUTUBE

February 27, 2017Ironwood Pharmaceuticals Youtube Channel

"Our Core Values: Ironwoodian, Trista M., on Innovation" on YOUTUBE

February 22, 2017Ironwood Pharmaceuticals Youtube Channel

"Our Core Values: Ironwoodian, Mike M., on Ownership" on YOUTUBE

February 13, 2017Ironwood Pharmaceuticals Youtube Channel

"Our Core Values: Ironwoodian, Raj. I, on Innovation" on YOUTUBE

January 4, 2016Ironwood Pharmaceuticals Youtube Channel

"Ironwood Employees Share a Message for People with IBS" on YOUTUBE

January 4, 2016Ironwood Pharmaceuticals Youtube Channel

"Ironwoodians Discuss Importance of Raising IBS Awareness" on YOUTUBE

Social Media

Ironwood Headquarters

100 Summer Street Suite 2300

Boston, Massachusetts02110

1-617-621-7722

Driving Directions »

Trending Companies

Ironwood Summary

ABOUT

Overview

Ironwood is a pharmaceutical company that develops and markets medicines for the treatment of irritable bowel syndrome and chronic idiopathic constipation. Ironwood was founded in 1998. Ironwood's headquarters is located in Boston, Massachusetts, USA ...

CEO

Ironwood's Interim-CEO, Thomas McCourt, currently has an approval rating of 83%. Ironwood's primary competitors are Albireo, Ardelyx & Endo.

Frequently Asked Questions about Ironwood

  1. When was Ironwood founded?

    Ironwood was founded in 1998
  2. Who is Ironwood's CEO?

    Ironwood's CEO is Thomas McCourt
  3. How much revenue does Ironwood generate?

    Ironwood generates $398.4M in revenue
  4. How much funding does Ironwood have?

    Ironwood has historically raised $652.8M in funding
  1. Where is Ironwood's headquarters?

    Ironwood's headquarters is in Boston Massachusetts, USA
  2. How many employees does Ironwood have?

    Ironwood has 515 employees
  3. What sector does Ironwood operate in?

    Ironwood is in Pharmaceuticals, Biotechnology
  4. Who are Ironwood's competitors?

    Ironwood's top competitors are Albireo, Ardelyx, Endo